Skip to content ↓

Topic

Medicine

Download RSS feed: News Articles / In the Media / Audio

Displaying 166 - 180 of 606 news clips related to this topic.
Show:

TechCrunch

Researchers at MIT are working on a system that can track the development of Parkinson’s disease by monitoring a person’s gait speed, reports Kyle Wiggers and Devin Coldewey for TechCrunch. “The MIT Parkinson’s-tracking effort aims to help clinicians overcome challenges in treating the estimated 10 million people afflicted by the disease globally,” writes Wiggers and Coldewey.

Boston.com

Researchers from MIT and Harvard Medical School are investigating how exercise and high-fat diets can alter cells, genes and cellular pathways, reports Abby Patkin for Boston.com. “Their research could eventually help develop drugs that would mimic the effects of exercise and combat obesity,” explains Patkin.

WCVB

Researchers from MIT and Harvard Medical School have conducted a study to see how exercise and high-fat diets can impact cells, reports WCVB. The researchers “say the data could eventually be used to develop drugs that could help enhance or mimic the benefits of exercise,” writes WCVB.

NBC Boston

A new study by researchers from MIT and Harvard Medical School has helped identify the impact of exercise and high-fat diets on cells, reports Darren Botelho for NBC Boston 10. “Years from now, those researchers say the data could lead to a pill that would help not only with weight loss, but with the overall effect from exercise – a better wellbeing,” explains Botelho.

Boston 25 News

Prof. Manolis Kellis speaks with Boston 25 about his team’s work exploring the underlying mechanisms exploring how exercise influences weight loss, findings that could offer potential targets for drugs that could help to enhance or mimic the benefits of exercise. “Such an intervention would be a complete game changer and the reason for that is that the obesity epidemic has led to the U.S. having a decreased life span compared to all other developed countries,” says Kellis.

Smithsonian Magazine

MIT researchers have created a robotic pill that can safely penetrate the mucus barrier in the digestive tract to deliver drugs more efficiently, reports Margaret Osborne for Smithsonian Magazine. “The device’s textured surface clears away the mucus, and the rotating motion erodes the compartment with the drug payload, which slowly releases into the digestive tract,” explains Osborne.

New York Times

Prof. Richard Hynes is one of the winners of this year’s Lasker Award, reports Benjamin Mueller for The New York Times, for his work describing how “cells bind to their surrounding networks of proteins and other molecules — findings that pointed the way toward treatments for a number of diseases.”

New Scientist

New Scientist reporter Alex Wilkins writes that MIT researchers have developed a robotic pill that can propel itself through mucus in the intestines and could enable some injection-only medications to be taken orally. “The pill is 2.5-centimeters long and 1-centimeter wide – about the size of a large multivitamin ­– and encased in a gelatin capsule that dissolves in stomach acid,” writes Wilkins. “The pH in the lower intestine activates the motor, which is powered by a small battery.”

Associated Press

Prof. Richard Hynes is one of three honorees for the Albert Lasker Basic Medical Research Award, reports Maddie Burakoff for the AP. Hynes and his fellow awardees “helped launch the field of integrin research, which has since led to new strategies for treating diseases,” writes Burakoff.

The Boston Globe

Prof. Richard Hynes is one of the three recipients of the 2022 Albert Lasker Basic Medical Research Award for his contributions to the field of integrin research, reports Martin Finucane for The Boston Globe. Hynes and his colleagues “provided a greater understanding of the diseases that can result when integrin function is perturbed.”

The Boston Globe

MIT researchers have developed a new in-home device that can help monitor Parkinson’s patients by tracking their gait, reports Hiawatha Bray for The Boston Globe. “We know very little about the brain and its diseases,” says Professor Dina Katabi. “My goal is to develop non-invasive tools that provide new insights about the functioning of the brain and its diseases.”

Popular Science

Popular Science reporter Philip Kiefer writes that MIT researchers have developed an in-home device that could be used to track the progression of symptoms in Parkinson’s patients. “We can’t really ask patients to come to the clinic every day or every week,” explains graduate student Yingcheng Liu. “This technology gives us the possibility to continuously monitor patients, and provide more objective assessments.”

Quartz

Graduate student Evan Soltas and Gopi Shah Goda, deputy director of Stanford’s Institute for Economic Policy Research, explore the impact that Covid-19 has had on the workforce, reports Sarah Todd for Quartz. “People ages 65 and up are more likely to leave the workforce after contracting Covid compared to younger people,” say Soltas and Goda.

The Guardian

A study by graduate student Evan Soltas and Gopi Shah Goda, deputy director of Stanford’s Institute for Economic Policy Research, underlines the pandemic’s impact on labor supply in the United States, reports Richard Luscombe for The Guardian. “Our estimates suggest Covid-19 illnesses have reduced the US labor force by approximately 500,000 people,” say Soltas and Goda.

Fortune

A study by graduate student Evan Soltas and Gopi Shah Goda, deputy director of Stanford’s Institute for Economic Policy Research, explores the economic toll of Covid-19, including acute illness and long Covid, reports Erin Prater for Fortune. The paper “also looks at the impact of other Covid-related medical consequences like organ damage, mental health issues, new kidney and heart problems, and the worsening of preexisting illness, in addition to the phenomenon of Covid forcing older workers into early retirement,” explains Prater.